Metraipolis › archive › dc_fd2388cae709
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum… — Europe PMC PMID:40914144
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40914144
- DOI
- 10.1016/j.tranon.2025.102520
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T03:01:23.764Z
- SHA-256 of the archived text
06f445311e31d3ab6c5ff84b15c9b2e3c4c6c852344cfefc17ca1f0c0a869037- Stable URL of this page
https://metraipolis.com/documento/dc_fd2388cae709
How to cite
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum… — Europe PMC PMID:40914144 — Europe PMC (en), https://europepmc.org/article/MED/40914144 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd2388cae709 (Metraipolis archive dc_fd2388cae709, sha256 06f445311e31d3ab6c5ff84b15c9b2e3c4c6c852344cfefc17ca1f0c0a869037)
BibTeX
@misc{dcfd2388cae709,
title = {MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum… — Europe PMC PMID:40914144},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40914144},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd2388cae709; sha256 06f445311e31d3ab6c5ff84b15c9b2e3c4c6c852344cfefc17ca1f0c0a869037},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40914144. Agents can read the archived copy with the MCP tool read_document.